E2F1 and hepatocellular carcinoma: Estimation of the prognostic value for E2F1 activity in HCC patients using TCGA-LIHC (372 patients) data set indicated that elevated E2F1 activity was highly correlated with poor overall survival (p = 0.00091) and disease-free survival (p = 0.00013) (Figure 4C).